The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
ThermoFisher Scientific Patheon Pharma Services
×
Recent searches Clear History
Suggestions
All Results
 Search
 US | EN

EU Clinical Trial Regulation 2022: Understanding the impact on clinical research in Europe

Whitepaper

Eight years after its adoption, the EU Clinical Trial Regulation (CTR) 2022 has come into full application, radically altering the regulatory landscape for conducting clinical trials in EU member states and European Economic Area (EEA) countries. This whitepaper provides insight into the key changes introduced by the regulation and guidance for managing anticipated challenges, focusing specifically on the following considerations:

  • The impact of the new regulation on existing clinical trials
  • The implications for good manufacturing practice (GMP) guidance and the Clinical Trial Application (CTA) process
  • New labelling requirements, the challenges they may pose, and potential solutions
  • The UK’s approach to clinical trial regulation and the impact of the EU CTR changes on Qualified Person (QP) requirements and other legislation